Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Frederic Jackson

Assay Scientist in Molecular Virology

Clinical BioManufacturing Facility (CBF)

Development of Next Generation Sequencing (NGS) as a Good Manufacturing Practice (GMP) assay to assess genetic stability of products and for the detection of adventitious agents as part of The Future Vaccine Manufacturing Research Hub (VaxHub).

My Role also includes the validation of other assays/equipment and to perform In-Process Quality Control (QC) testing as a member of the QC department.